Financial Toxicity in Patients With Cancer: What a Tangled Web We Weave

Author: Benyam Muluneh PharmD, BCOP, CPP
View More View Less
Restricted access

Disclosures: Dr. Muluneh has disclosed that he has not received any financial considerations from any person or organization to support the preparation, analysis, results, or discussion of this article.

Correspondence: Benyam Muluneh, PharmD, BCOP, CPP, University of North Carolina Eshelman School of Pharmacy, 301 Pharmacy Lane, CB 7569, Chapel Hill, NC 27599. Email: bmuluneh@unc.edu
  • 1.

    Scott W. Marmion: A Tale of Flodden Field. Edinburgh, England: J. Ballantyne and Co.; 1808.

    • Crossref
    • Export Citation
  • 2.

    What Medicare Part D drug plans cover. Accessed August 2, 2020. Available at: https://www.medicare.gov/drug-coverage-part-d/what-medicare-part-d-drug-plans-cover

  • 3.

    Criminal Penalties for Acts Involving Federal Health Care Programs, 42 USC §1320a–7b (2010). Accessed August 2, 2020. Available at: https://www.law.cornell.edu/uscode/text/42/1320a-7b

  • 4.

    Jamy O, Xavier AC, Costa LJ. Impact of insurance status on survival of patients diagnosed with acute promyelocytic leukemia in the United States [abstract]. Blood 2018;132(Suppl 1):Abstract 321.

    • Crossref
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1851 1851 39
PDF Downloads 264 264 16
EPUB Downloads 0 0 0